相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease
Vera Karamfilova et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study
Yingying Gu et al.
ANNALS OF NUTRITION AND METABOLISM (2022)
Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway
Alina Abdolahi et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
A new immunometabolic perspective of intervertebral disc degeneration
Vera Francisco et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis
Manqiu Mo et al.
DIGESTIVE AND LIVER DISEASE (2022)
A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease
Cecilia C. Garcia et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis
Qian Ren et al.
LIPIDS IN HEALTH AND DISEASE (2022)
Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes
Ali Saeed et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
Anat Yaskolka Meir et al.
GUT (2021)
Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice
Fengyun Wen et al.
HORMONE AND METABOLIC RESEARCH (2021)
Ghrelin ameliorates nonalcoholic steatohepatitis induced by chronic low-grade inflammation via blockade of Kupffer cell M1 polarization
Yue Yin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway
Xiuqin An et al.
PEPTIDES (2021)
Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes
Morten Dall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model
Yu Jung Heo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior
Emanuela Micioni Di Bonaventura et al.
PHARMACOLOGICAL RESEARCH (2021)
Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells
Xiaoping Wu et al.
ADVANCED SCIENCE (2021)
Regulation of macrophage functions by FABP-mediated inflammatory and metabolic pathways
Rong Jin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2021)
A-FABP in Metabolic Diseases and the Therapeutic Implications: An Update
Hang-Long Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease
Susrichit Phrueksotsai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease
Seidamir Pasha Tabaeian et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2021)
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
Amalia Gastaldelli et al.
LIVER INTERNATIONAL (2021)
Retinol-binding protein 4 in obesity and metabolic dysfunctions
Pamela A. Nono Nankam et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
Qiong Wei et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The GG genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease
Gholamreza Rezamand et al.
PHYSIOLOGY INTERNATIONAL (2021)
Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
Abdulrahman Ismaiel et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Role of Leptin in Non-Alcoholic Fatty Liver Disease
Carlos Jimenez-Cortegana et al.
BIOMEDICINES (2021)
Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings
Baris Akinci et al.
MED (2021)
Current treatment paradigms and emerging therapies for NAFLD/NASH
Sana Raza et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2021)
Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block
Vasilios G. Athyros et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease
X. Wang et al.
DIABETES & METABOLISM (2020)
Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats
S. Ezquerro et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
Ghrelin and liver disease
Mar Quinones et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter
Zeinab Anwar Elkabany et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
Vian Azzu et al.
GASTROENTEROLOGY (2020)
New drugs for NAFLD: lessons from basic models to the clinic
Katharina C. Reimer et al.
HEPATOLOGY INTERNATIONAL (2020)
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Shamir Cassim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An MRM-Based Multiplexed Quantification Assay for Human Adipokines and Apolipoproteins
Laura Krieg et al.
MOLECULES (2020)
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Federica Zatterale et al.
FRONTIERS IN PHYSIOLOGY (2020)
Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels
Ahmed Abdallah Salman et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis
Vera Francisco et al.
NUTRIENTS (2020)
Metformin and Its Benefits for Various Diseases
Ziquan Lv et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?
Misaq Heydari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Amelio F. Godoy-Matos et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases
Maite Martinez-Una et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Adiponectin: Role in physiology and pathophysiology
Thi Diep Nguyen
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2020)
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation
Eman F. Khaleel et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Resistin: A reappraisal
E. Acquarone et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2019)
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
Peter Delbert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Association Between Visfatin and Hepatic Steatosis in the General Population During Long-Term Follow-Up
Katharina Johannsen et al.
HORMONE AND METABOLIC RESEARCH (2019)
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis
Christopher L. Cioffi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells
Ying Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
An introduction to clinical trial design
A. Schultz et al.
PAEDIATRIC RESPIRATORY REVIEWS (2019)
Visfatin Induces Inflammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes
Yu Jung Heo et al.
JOURNAL OF DIABETES RESEARCH (2019)
Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals
Yiting Xu et al.
LIVER INTERNATIONAL (2019)
Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models
Ashfaq Ahmad et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/ PKC/JNK pathway
Mohammad A. Dallak
BIOMEDICINE & PHARMACOTHERAPY (2018)
Thiazolidinediones as antidiabetic agents: A critical review
M. J. Nanjan et al.
BIOORGANIC CHEMISTRY (2018)
Adipokines and inflammation: is it a question of weight?
Vera Francisco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
Fernando Bril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Rocio Aller et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2018)
Chemerin: a multifaceted adipokine involved in metabolic disorders
Gisela Helfer et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus
Zhengjun Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Obesity, Fat Mass and Immune System: Role for Leptin
Vera Francisco et al.
FRONTIERS IN PHYSIOLOGY (2018)
Metformin: An Old Drug with New Applications
Joseph Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
Simona Leoni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts
Margarita Papatheodoridi et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Chrysoula Boutari et al.
ENDOCRINOLOGY AND METABOLISM (2018)
Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C/EBPα-p300/DGAT1 pathway
Bobby Guillory et al.
AGING CELL (2018)
ARE VASPIN AND OMENTIN-1 RELATED TO INSULIN RESISTANCE, BLOOD PRESSURE AND INFLAMMATION IN NAFLD PATIENTS?
Fereshteh Aliasghari et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2018)
Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis
Rebekka Pohl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Novel Plasma Biomarkers Associated With Liver Disease Severity in Adults With Nonalcoholic Fatty Liver Disease
Veeral Ajmera et al.
HEPATOLOGY (2017)
Response to: Comment to EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2017)
Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease
Farzaneh Montazerifar et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2017)
Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Zhongwei Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
Ling-Fang Wang et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Association between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease
Bahareh Amirkalali et al.
MEDICAL PRINCIPLES AND PRACTICE (2017)
Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity
Vikrant Rachakonda et al.
OBESITY (2017)
EXPRESSION OF RESISTIN IN THE LIVER OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Piotr Gierej et al.
POLISH JOURNAL OF PATHOLOGY (2017)
HEPATIC CHEMERIN MRNA IN MORBIDLY OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Maciej Kajor et al.
POLISH JOURNAL OF PATHOLOGY (2017)
Engineering in vitro models of hepatofibrogenesis
Giuseppe Mazza et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis
Adnan Said et al.
ANNALS OF HEPATOLOGY (2017)
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin
Federico Carbone et al.
COMPREHENSIVE PHYSIOLOGY (2017)
Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review
M. Bekaert et al.
OBESITY REVIEWS (2016)
Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy
Cristina Adelia Meehan et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Shehab M. Abd El-Kader et al.
AFRICAN HEALTH SCIENCES (2016)
Best practice for analysis of shared clinical trial data
Sally Hollis et al.
BMC MEDICAL RESEARCH METHODOLOGY (2016)
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk
Jennifer H. Stern et al.
CELL METABOLISM (2016)
Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice
Seung-Ah Lee et al.
HEPATOLOGY (2016)
Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis
Yan Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Adipokines in in nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity
Marlies Bekaert et al.
Obesity (2016)
Acylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats
Silvia Ezquerro et al.
SCIENTIFIC REPORTS (2016)
Ghrelin Attenuated Lipotoxicity via Autophagy Induction and Nuclear Factor-kappa B Inhibition
Yuqing Mao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis
Rebekka Pohl et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Leptin in nonalcoholic fatty liver disease: A narrative review
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Adipocytokines and hepatic fibrosis
Neeraj K. Saxena et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Regulation of adiponectin multimerization, signaling and function
Meilian Liu et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis
Chuan Shen et al.
BMC GASTROENTEROLOGY (2014)
Role of leptin in energy homeostasis in humans
Michael Rosenbaum et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Leptin in common obesity and associated disorders of metabolism
Alex M. DePaoli
JOURNAL OF ENDOCRINOLOGY (2014)
Synthesis and Biological Evaluation of Novel Urea- and Guanidine-Based Derivatives for the Treatment of Obesity-Related Hepatic Steatosis
Xiaolin Liang et al.
MOLECULES (2014)
Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice
Nanda Gruben et al.
PLOS ONE (2014)
Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease
Jun-Bin Suh et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents
N. Arslan et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children
Monika Klusek-Oksiuta et al.
ITALIAN JOURNAL OF PEDIATRICS (2014)
Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease
Teresa Auguet et al.
CLINICAL BIOCHEMISTRY (2013)
Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
S. Doecke et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver
Sabrina Krautbauer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β
Rongjing Song et al.
GENE (2013)
The liver diseases of lipodystrophy: The long-term effect of leptin treatment
Elika Safar Zadeh et al.
JOURNAL OF HEPATOLOGY (2013)
Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice
Ruby L. C. Hoo et al.
JOURNAL OF HEPATOLOGY (2013)
Serum Retinol-binding Protein 4 Is Independently Associated With Pediatric NAFLD and Fasting Triglyceride Level
Shu-Ching Huang et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
Resistin mediates the hepatic stellate cell phenotype
Zhi-Xia Dong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease
Halit Genc et al.
ANNALS OF HEPATOLOGY (2013)
Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index
Stergios A. Polyzos et al.
ANNALS OF HEPATOLOGY (2013)
Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development
Yan Li et al.
ENDOCRINE (2013)
Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
Marina Shargorodsky et al.
CARDIOVASCULAR DIABETOLOGY (2012)
How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease
Mariana V. Machado et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Hepatic Progenitor Cells Activation, Fibrosis, and Adipokines Production in Pediatric Nonalcoholic Fatty Liver Disease
Valerio Nobili et al.
HEPATOLOGY (2012)
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
Jiayun Shen et al.
JOURNAL OF HEPATOLOGY (2012)
Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients
Edith Koehler et al.
LIVER INTERNATIONAL (2012)
Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH
Min Yong Yoon et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism
Benjamin Bondue et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
Zobair M. Younossi et al.
OBESITY SURGERY (2011)
Association of Obestatin, Ghrelin, and Inflammatory Cytokines in Obese Patients with Non-alcoholic Fatty Liver Disease
Michael Estep et al.
OBESITY SURGERY (2011)
Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis
Laszlo Otvos et al.
PEPTIDES (2011)
Rosiglitazone Revisited An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality
Steven E. Nissen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cem Cengiz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery
Henrike Sell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease
Tuva B. Dahl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
Radhika Gaddipati et al.
ANNALS OF HEPATOLOGY (2010)
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome
Lucia Pacifico et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Adipocyte Fatty Acid Binding Protein Levels Relate to Inflammation and Fibrosis in Nonalcoholic Fatty Liver Disease
Kerry-Lee Milner et al.
HEPATOLOGY (2009)
Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery
Marianna Argentou et al.
OBESITY SURGERY (2009)
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice
Neel S. Singhal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
J. A. Seo et al.
CLINICAL ENDOCRINOLOGY (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
New role of resistin in lipopolysaccharide-induced liver damage in mice
Juliane I. Beier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
Zobair M. Younossi et al.
OBESITY SURGERY (2008)
Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease
Rocio Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Adipokines and cytokines in non-alcoholic fatty liver disease
M. H. Jarrar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme
Javier R. Revollo et al.
CELL METABOLISM (2007)
Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome
Rocco Barazzoni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Chemerin is a novel adipokine associated with obesity and metabolic syndrome
Kiymet Bozaoglu et al.
ENDOCRINOLOGY (2007)
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
Glen Lutchman et al.
HEPATOLOGY (2007)
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans
Norbert Stefan et al.
DIABETES CARE (2007)
Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation
Prabhakaran Balagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects
Dominik G. Haider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women
David H. St-Pierre et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
C Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Adipokines in NASH:: Postprandial lipid metabolism as a link between adiponectin and liver disease
G Musso et al.
HEPATOLOGY (2005)
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy
ED Javor et al.
HEPATOLOGY (2005)
Activation of SOCS-3 by resistin
CM Steppan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference
P Magni et al.
CLINICAL ENDOCRINOLOGY (2005)
Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor
ML Narasimhan et al.
MOLECULAR CELL (2005)
Regulation of fasted blood glucose by resistin
RR Banerjee et al.
SCIENCE (2004)
Role of resistin in diet-induced hepatic insulin resistance
ED Muse et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance
G Marchesini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The hormone resistin links obesity to diabetes
CM Steppan et al.
NATURE (2001)
分享论文
